Company / Income Tax
Sarepta Therapeutics Income Tax History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$11.2M
FY2025
5-year range
-$168.0K / $25.5M
FY2021-FY2025
Trend
-56.2%
vs FY2024
Sector context
#46 of 204
Health Care
What the data says
Sarepta Therapeutics's income tax of $11M is higher than 77% of companies in the Health Care sector (FY2025). Income Tax has fluctuated over the past 9 years, ranging from -$692,000 in FY2020 to $26M in FY2024.
Based on SEC 10-K filings.
$11M in FY2025 with a 3-year CAGR of +119.1%. Top quartile in the Health Care sector.
Improved from $16M to $11M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- +119.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 204This company $11.2M Sector average $118.7M
▼
-90.6% below sector average
Key checks
Key Insights
- 3-year CAGR of +119.1%, indicating consistent growth.
- In FY2025, income tax decreased 56.2% year-over-year.
- Ranks #46 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.2M | -56.2% |
| FY2024 | $25.5M | +60.8% |
| FY2023 | $15.9M | +1393.8% |
| FY2022 | $1.1M | +732.7% |
| FY2021 | -$168.0K | +75.7% |
| FY2020 | -$692.0K | -133.6% |
| FY2019 | $2.1M | +397.7% |
| FY2018 | -$692.0K | -133.6% |
| FY2017 | $2.1M | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026